134 related articles for article (PubMed ID: 1980613)
1. Neuroleptic drug effects on cognitive function in schizophrenia.
Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM
Schizophr Res; 1990; 3(3):211-9. PubMed ID: 1980613
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic effects on neuropsychological test performance in schizophrenia.
Verdoux H; Magnin E; Bourgeois M
Schizophr Res; 1995 Jan; 14(2):133-9. PubMed ID: 7710993
[TBL] [Abstract][Full Text] [Related]
3. Relationships between medication treatments and neuropsychological test performance in schizophrenia.
Sweeney JA; Keilp JG; Haas GL; Hill J; Weiden PJ
Psychiatry Res; 1991 Jun; 37(3):297-308. PubMed ID: 1679950
[TBL] [Abstract][Full Text] [Related]
4. Cognitive disturbances in neuroleptic therapy.
Strauss WH; Klieser E
Acta Psychiatr Scand Suppl; 1990; 358():56-7. PubMed ID: 1978491
[TBL] [Abstract][Full Text] [Related]
5. Do neuroleptics impair learning in schizophrenic patients?
Cutmore TR; Beninger RJ
Schizophr Res; 1990; 3(3):173-86. PubMed ID: 1980612
[TBL] [Abstract][Full Text] [Related]
6. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.
Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM; Franco S
J Clin Psychiatry; 1991 Jan; 52(1):26-30. PubMed ID: 1671032
[TBL] [Abstract][Full Text] [Related]
7. Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings.
Finkelstein JR; Cannon TD; Gur RE; Gur RC; Moberg P
J Abnorm Psychol; 1997 May; 106(2):203-12. PubMed ID: 9131840
[TBL] [Abstract][Full Text] [Related]
8. Performance of long-stay schizophrenics after drug withdrawal on matched immediate and delayed recall tasks.
Calev A; Nigal D; Kugelmass S; Weller MP; Lerer B
Br J Clin Psychol; 1991 Sep; 30(3):241-5. PubMed ID: 1681971
[TBL] [Abstract][Full Text] [Related]
9. [Tolerance of neuroleptics, deficit syndrome and cognitive functions].
Kahn JP
Encephale; 1996 Jun; 22 Spec No 2():49-54. PubMed ID: 8767043
[TBL] [Abstract][Full Text] [Related]
10. The effect of risperidone on cognition in patients with schizophrenia.
Stip E; Lussier I
Can J Psychiatry; 1996 Oct; 41(8 Suppl 2):S35-40. PubMed ID: 8899249
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction.
Seidman LJ; Pepple JR; Faraone SV; Kremen WS; Green AI; Brown WA; Tsuang MT
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):575-84. PubMed ID: 8101100
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic-induced deficit syndrome (NIDS).
J Clin Psychiatry; 1993 Dec; 54(12):493-500. PubMed ID: 7903967
[No Abstract] [Full Text] [Related]
13. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
Nagase Y; Okubo Y; Toru M
Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological test scores and clinical response to neuroleptic drugs in schizophrenic patients.
Smith RC; Largen J; Vroulis G; Ravichandran GK
Compr Psychiatry; 1992; 33(2):139-45. PubMed ID: 1347499
[TBL] [Abstract][Full Text] [Related]
15. Smooth pursuit eye movements in schizophrenia: influences of neuroleptic treatment and the question of specificity.
Küfferle B; Friedmann A; Topitz A; Földes P; Anderer P; Kutzer M; Steinberger K
Psychopathology; 1990; 23(2):106-14. PubMed ID: 1979684
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia.
Gold S; Arndt S; Nopoulos P; O'Leary DS; Andreasen NC
Am J Psychiatry; 1999 Sep; 156(9):1342-8. PubMed ID: 10484943
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
18. Working memory and depressive symptoms in patients with schizophrenia and substance use disorders.
Potvin S; Pampoulova T; Lipp O; Ait Bentaleb L; Lalonde P; Stip E
Cogn Neuropsychiatry; 2008 Jul; 13(4):357-66. PubMed ID: 18622790
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A
Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040
[TBL] [Abstract][Full Text] [Related]
20. First-episode schizophrenia patients neuropsychologically within the normal limits: evidence of deterioration in speed of processing.
González-Blanch C; Rodríguez-Sánchez JM; Pérez-Iglesias R; Pardo-García G; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Schizophr Res; 2010 Jun; 119(1-3):18-26. PubMed ID: 20335007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
